List of Excipients in API brimonidine tartrate ophthalmic solution, 0.15%
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing brimonidine tartrate ophthalmic solution, 0.15%
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 | BORIC ACID |
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 | CALCIUM CHLORIDE |
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 | CARBOXYMETHYLCELLULOSE SODIUM |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for brimonidine tartrate ophthalmic solution, 0.15%
Excipient focus: BORIC ACID
brimonidine tartrate ophthalmic solution, 0.15% drug variants containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 |
| Alembic Pharmaceuticals Inc | brimonidine tartrate ophthalmic solution, 0.15% | 62332-661 |
| >Company | >Ingredient | >NDC |
brimonidine tartrate ophthalmic solution, 0.15% drug variants not containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM CHLORIDE
brimonidine tartrate ophthalmic solution, 0.15% drug variants containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 |
| Alembic Pharmaceuticals Inc | brimonidine tartrate ophthalmic solution, 0.15% | 62332-661 |
| >Company | >Ingredient | >NDC |
brimonidine tartrate ophthalmic solution, 0.15% drug variants not containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
brimonidine tartrate ophthalmic solution, 0.15% drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 |
| Alembic Pharmaceuticals Inc | brimonidine tartrate ophthalmic solution, 0.15% | 62332-661 |
| >Company | >Ingredient | >NDC |
brimonidine tartrate ophthalmic solution, 0.15% drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
brimonidine tartrate ophthalmic solution, 0.15% drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 |
| Alembic Pharmaceuticals Inc | brimonidine tartrate ophthalmic solution, 0.15% | 62332-661 |
| >Company | >Ingredient | >NDC |
brimonidine tartrate ophthalmic solution, 0.15% drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM CHLORIDE
brimonidine tartrate ophthalmic solution, 0.15% drug variants containing MAGNESIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 |
| Alembic Pharmaceuticals Inc | brimonidine tartrate ophthalmic solution, 0.15% | 62332-661 |
| >Company | >Ingredient | >NDC |
brimonidine tartrate ophthalmic solution, 0.15% drug variants not containing MAGNESIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
brimonidine tartrate ophthalmic solution, 0.15% drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 |
| Alembic Pharmaceuticals Inc | brimonidine tartrate ophthalmic solution, 0.15% | 62332-661 |
| >Company | >Ingredient | >NDC |
brimonidine tartrate ophthalmic solution, 0.15% drug variants not containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BORATE
brimonidine tartrate ophthalmic solution, 0.15% drug variants containing SODIUM BORATE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 |
| Alembic Pharmaceuticals Inc | brimonidine tartrate ophthalmic solution, 0.15% | 62332-661 |
| >Company | >Ingredient | >NDC |
brimonidine tartrate ophthalmic solution, 0.15% drug variants not containing SODIUM BORATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
brimonidine tartrate ophthalmic solution, 0.15% drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 |
| Alembic Pharmaceuticals Inc | brimonidine tartrate ophthalmic solution, 0.15% | 62332-661 |
| >Company | >Ingredient | >NDC |
brimonidine tartrate ophthalmic solution, 0.15% drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
brimonidine tartrate ophthalmic solution, 0.15% drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 |
| Alembic Pharmaceuticals Inc | brimonidine tartrate ophthalmic solution, 0.15% | 62332-661 |
| >Company | >Ingredient | >NDC |
brimonidine tartrate ophthalmic solution, 0.15% drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
brimonidine tartrate ophthalmic solution, 0.15% drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | brimonidine tartrate ophthalmic solution, 0.15% | 46708-661 |
| Alembic Pharmaceuticals Inc | brimonidine tartrate ophthalmic solution, 0.15% | 62332-661 |
| >Company | >Ingredient | >NDC |
brimonidine tartrate ophthalmic solution, 0.15% drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch